Mainland China

Huami Enters in Definitive Agreement to Acquire a Minority Stake in Jiangsu Yitong High-Tech Co., Ltd. to expand the healthcare ecosystem for Chinese market

BEIJING, Jan. 5, 2021 /PRNewswire/ -- Huami Corp. (NYSE: HMI) today announced that it has entered into an agreement to acquired 29.99% of the outstanding shares of Jiangsu Yitong Hi-Tech Co., Ltd., (Shenzhen: 300211) for an aggregate consideration ofRMB959.68 million (US$147.08 million) in cash. ...

2021-01-05 20:05 10877

Supreme Court's Final Judgement Rejects All of RBVC Claims to The Red Bull Trademark Ownership

BEIJING, Jan. 5, 2021 /PRNewswire/ -- On December 21, 2020 - the Supreme People's Court  (Supreme Court) rendered a final judgment in the trademark ownership case between Red Bull Vitamin Drink Co., Ltd. (RBVC, controlled by Mr. Yan Bin) and T.C. Pharmaceutical Industries Co., Ltd. (TCP) -- the j...

2021-01-05 19:11 5321

vivo Announces Comprehensive Developer Platform Upgrades at VDC 2020

SHENZHEN, China, Jan. 5, 2021 /PRNewswire/ -- vivo recently showcased the spectacular overseas performance of V-Appstore and revealed a variety of upcoming enhancements to the global vivo Developers Platform ecosystem at the vivo Developers Conference, which was held inShenzhen last November. The...

2021-01-05 19:05 2271

Four Seasons Education to Report Third Quarter Fiscal Year 2021 Unaudited Financial Results

SHANGHAI, Jan. 5, 2021 /PRNewswire/ -- Four Seasons Education (Cayman) Inc. ("Four Seasons Education" or the "Company") (NYSE: FEDU), a leadingShanghai based educational company dedicated to providing comprehensive after-school education services with a focus on high-quality math education, today...

2021-01-05 19:00 3617

SMIC Announces Fourth Quarter 2020 Webcast Conference Call

SHANGHAI, Jan. 5, 2021 /PRNewswire/ --  Please join SMIC's earnings conference call. The fourth quarter 2020 results will be released and available at http://www.smics.com/en/  after the close of trading on the Hong Kong Stock Exchange (HKEX) and Shanghai Stock Exchang...

2021-01-05 18:37 6119

Chiauranib, an Anti-tumor Drug Developed by Chipscreen, is Given CDE "Breakthrough Therapy Designation"

SHENZHEN, China, Jan. 5, 2021 /RPNewswire/ -- Last December 25, the anti-tumor drug candidate Chiauranib, developed by Shenzhen Chipscreen Biosciences Co., Ltd., was granted with the "Breakthrough Therapy Designation Drug" by the Center for Drug Evaluation (CDE) and currently enter a phase III cl...

2021-01-05 17:49 2394

KFC and Pizza Hut Launch New Plastic Reduction Initiatives in China

* Yum China steps up efforts to provide sustainable options for consumers * 30% reduction of non-degradable plastic packaging weight by 2025 SHANGHAI, Jan. 5, 2021 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China", NYSE: YUMC and HKEX: 9987) announced that it has launched ...

2021-01-05 16:30 3815

Xinhua Silk Road: 1st Guiping China International Cultural Tourism and Casual Sportswear Festival kicks off in S China's Guangxi

BEIJING, Jan. 5, 2021 /PRNewswire/ -- The First Guiping China International Cultural Tourism and Casual Sportswear Festival kicked off at Mule Town in Guiping City of southChina's Guangxi Zhuang Autonomous Region last Friday. 1st Guiping China Int...

2021-01-05 16:02 1871

KFC and Pizza Hut Launch New Plastic Reduction Initiatives in China

* Yum China steps up efforts to provide sustainable options for consumers * 30% reduction of non-degradable plastic packaging weight by 2025 SHANGHAI, Jan. 5, 2021 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China", NYSE: YUMC and HKEX: 9987) announced that it has launched ...

2021-01-05 16:00 4134

Wei Zhou from CCV was awarded 2020 China's Best Venture Capitalists by Forbes for a fourth consecutive year

BEIJING, Jan. 5, 2021 /PRNewswire/ -- Recently, Forbes China released the "2020 China's Best Venture Capitalists" list, and Mr.Wei Zhou, Founding Managing Partner of China Creation Ventures (hereinafter referred to as "CCV"), was ranked 23rd in "China's Best Venture Capitalists". It is the fo...

2021-01-05 15:36 2164

Nippon Express (Shenzhen) Renamed Nippon Express Logistics (China)

TOKYO, Jan. 5, 2021 /PRNewswire/ -- Nippon Express (Shenzhen) Co., Ltd. (hereinafter "NE Shenzhen"), a Shenzhen, China-based local subsidiary of Nippon Express Co., Ltd., has changed its name to Nippon Express Logistics (China) Co., Ltd. (hereinafter "NE Logistics China"), effectiveSunday, Novemb...

2021-01-05 15:00 2635

Hitachi Elevator Delivers the 2020's 120,000th Elevator to China National Convention Center

TIANJIN, China, Jan. 5, 2021 /PRNewswire/ -- On December 29, Hitachi Elevator ( China) Co., Ltd. held the delivery ceremony of the 2020's 120,000th elevator at its factory in Tianjin. Wang Zhidong, Deputy District Head of Baodi District, Tianjin; Jia Yuhui, President of Hitachi Elevator; Liang Yaoq...

2021-01-05 14:36 3553

Looking Back at 2020: An Extraordinary Year for Cheung Kong Graduate School of Business

BEIJING, Jan. 5, 2021 /PRNewswire/ -- 2020 was undoubtedly a year of challenges, but it was also a year of triumphs. Whilst the pandemic caused global chaos and uncertainty, it also saw courage, determination and resilience. It forced us all to think outside of the box, identify growth opportuni...

2021-01-05 13:07 2329

Y-Biologics signed License Agreement with 3D Medicines for T cell bispecific engager in Greater China territory

DAEJEON, South Korea and SHANGHAI, Jan. 5, 2021 /PRNewswire/ -- The South Korean biotech company Y-Biologics and theChina-based biopharmaceutical company 3D Medicines have entered into a License Agreement granting exclusive rights to develop, manufacture, and commercialize YBL-013, a T cell bi-sp...

2021-01-05 09:00 2296

Ascentage Pharma Announces its 9th Orphan Drug Designation from the US FDA in 2020, Setting a Record for Chinese Biopharmaceutical Companies

SUZHOU, China and ROCKVILLE, Md., Jan. 5, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug Adm...

2021-01-05 08:32 2486

Antengene Announces Submission of IND Application in China for a Global Phase 3 Trial of ATG-010 (Selinexor) in Advanced or Recurrent Endometrial Cancer

SHANGHAI and HONG KONG, Jan. 5, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncolo...

2021-01-05 08:00 3227

China Liberal Education Holdings Limited Enters into Non-Binding Letter of Intent to Acquire Wanzhong (Hong Kong) Education Investment Management Co., Ltd

BEIJING, Jan. 4, 2021 /PRNewswire/ -- China Liberal Education Holdings Limited (Nasdaq: CLEU) ("China Liberal", or the "Company", or "we"), an educational services provider inChina, today announced that the Company has entered into a non-binding letter of intent (the "LOI") to acquire Wanzhong (H...

2021-01-04 22:25 11401

The Second Annual Award Ceremony for International Video Contest of My China Story held in Yantai

BEIJING, Jan. 4, 2021 /PRNewswire/ -- Nearing the end of 2020, an eventful year for most, China International Publishing Group (CIPG) hosts the My China Story award ceremony for excellent films created by foreigners both abroad and living inChina. Content creators from around the world document t...

2021-01-04 22:00 2109

Blue Hat Announces Further Growth of Xunpusen Following Company's Strategic Acquisition in 2020

XIAMEN, China, Jan. 4, 2021 /PRNewswire/ -- Blue Hat Interactive Entertainment Technology ("Blue Hat" or the "Company") (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality ("AR") interactive entertainment games, toys and educational materials inChina, today announced t...

2021-01-04 22:00 6653

Yuanyuan's Adventure Episode III: Taiwan Reunification

BEIJING, Jan. 4, 2021 /PRNewswire/ -- A news report by China.org.cn:   In the Kangxi period of the Qing Dynasty, the Zheng family, which was headed by the descendants of Zheng Chenggong, ruledTaiwan, and contended with the Qing government. Despite several rounds of peace negotia...

2021-01-04 21:01 2042